Sort
82,697 grants matching “vaccine development”
Epigenomic analysis of primary immune cells from young and old animals
$2,517,685Myong-Hee Sung · National Institute On Aging · ZIA · FY2019 · AG
DEVELOPMENT OF A NOVEL MULTIENVELOPE AIDS VACCINE
$2,517,641St. Jude Children'S Research Hospital · P01 · FY2001 · AI
Influenza Viral Pathogenesis
$2,517,484Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
HPV Vaccine Trial
$2,517,098Allan Hildesheim · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA
Project 1: Immune Memory
$2,516,756Rafi Ahmed · Emory University · U19 · FY2021 · AI
University of Washington Vaccine and Treatment Evaluation Unit
$2,516,717Anna Wald · University Of Washington · UM1 · FY2021 · AI
HIV/SIV Data Base and Analysis Unit
$2,516,282National Institute Of Allergy And Infectious Diseases · Y01 · FY2012 · AI
The Biology of HIV Infections
$2,516,195Malcolm Martin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
$2,515,245David Burkhart · Inimmune Corporation · N01 · FY2024 · AI
Novel SIVsmm strains for analysis of mucosal transmission and vaccine protection
$2,514,879George M Shaw · University Of Pennsylvania · P01 · FY2014 · AI
Pandemic Influenza Translational Research; Novel Vaccine and Drug Therapy
$2,514,389Matthew Memoli · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Livestock Movements and Disease Epidemiology in the Chad Basin: Modeling Risks for Animals and Humans
$2,514,105Rebecca Garabed · Ohio State University, The · · FY2010 · BIO
Development of Broadly Immunogenic and Universal Influenza Virus Vaccines
$2,513,196Audray Harris · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Nano Approaches to Modulate Host Cell Response for Cancer Therapy
$2,512,234Leaf Huang · Univ Of North Carolina Chapel Hill · U54 · FY2016 · CA
High Titer VIG for the Treatment of Smallpox
$2,511,835Omrix Biopharmaceuticals, Ltd · U01 · FY2003 · AI
Center/Coordination, Analysis and Management/MACS
$2,510,945Lisa P Jacobson · Johns Hopkins University · U01 · FY2009 · AI
Center for the Analysis & Management of the Multicenter AIDS Cohort Study
$2,510,945Lisa P Jacobson · Johns Hopkins University · U01 · FY2009 · AI
Translational Immunology Research and Accelerated [vaccine] Development (TRIAD)
$2,510,904Anne Searls De Groot · University Of Rhode Island · U19 · FY2011 · AI
Malaria Vaccines: TBV Antigens as Conjugates with Alternate Carriers
$2,510,151Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Fred Hutchinson Cancer Research Center Lung SPORE
$2,509,264A. McGarry Houghton · Fred Hutchinson Cancer Research Center · P50 · FY2020 · CA
SPORE IN BREAST CANCER
$2,508,532University Of Alabama At Birmingham · P50 · FY2004 · CA
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
$2,508,454Jamey P Weichert · University Of Wisconsin-Madison · P01 · FY2021 · CA
Nonhuman Primate Core Humoral Immunology Laboratory for AIDS Vaccine Research and Development
$2,507,678Shaunna Shen · Duke University · N01 · FY2023 · AI
Programming Long-lasting Immunity to Coronaviruses (PLUTO)
$2,506,857Viviana A Simon · Icahn School Of Medicine At Mount Sinai · P01 · FY2023 · AI
BSL3 management and practice of infectious disease research at HTRL
$2,506,378Dominique M Missiakas · University Of Chicago · UC7 · FY2025 · AI